目的 了解风湿骨痛胶囊门诊治疗各种疾病的情况,为临床安全、合理用药提供参考.方法 选取2016年7—12月上海市闵行区古美社区卫生服务中心门诊医师开具的单一诊断,使用风湿骨痛胶囊的处方655张,统计患者的性别、年龄、临床诊断、用法用量等.结果 655例使用风湿骨痛胶囊患者中,男296例,女359例;年龄16~92岁,平均年龄(67.2±13.9)岁,以60岁及以上的老年患者为主〔76.79%(503/655)〕,60~89岁占主导〔75.57%(495/655)〕.单一诊断涉及的疾病有39种,其中骨关节炎、骨质增生、关节炎、腰痛、关节痛居前5位,占59.39%(389/655).符合每次剂量(0.6~1.2 g)有644例(98.32%),符合每日用量(1.2~2.4 g)有299例(45.65%).结论 门诊风湿骨痛胶囊使用基本合理,但仍存在用药剂量偏大,应加强对含毒性成分方剂的监管.%Objective To understand outpatient use of Fengshi Gutong capsules in the treatment of various diseases,so that referencing for safe and appropriate use of medicines in clinical practice is available.Methods A total of 655 cases of patients with single-diagnosis disorders being prescribed Fengshi Gutong capsules at Gumei Community Health Service Center,Minhang District of Shanghai City,between July and December 2016,were selected for analysis.Gender,age, clinical diagnosis,and treatment regimen was collected and analyzed.Results The 655 patients administered with Fengshi Gutong capsules consisted of 296 men and 359 women,with ages ranging from 16 to 92 years (mean 67.2 ± 13.9 years).Of the patients,76.79% (503/655) were at least 60 years old,and 75.57% (495/655) were aged from 60 to 89 years.A total of 39 diseases were diagnosed,with osteoarthritis,hyperosteogeny,arthritis,lumbago,and arthralgia accounting for 59.39% (389/655) of all diagnoses.Six hundred and forty-four (98.32%) patients followed each dose (0.6 to 1.2 g),and 299 (45.65%) patients followed a daily dose (1.2 to 2.4 g).Conclusion Current outpatient use of Fengshi Gutong capsules is almost appropriate,however,current doses are slightly higher than necessary.The supervision of prescriptions containing toxic ingredients should be strengthened.
展开▼
